Clene CLNN
NASDAQ CLNN
$3.88 +0.12 (+3.19%)
At close: Oct 22, 2026 · 4:00 PM EDT

Clene (CLNN) Preferred Stock Liabilities (2019)

Updated

Clene (CLNN) recorded Preferred Stock Liabilities of $72.66 million in Q4 2019.

Analysis

Clene (CLNN) Preferred Stock Liabilities (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Clene 49.58 Mn 19.51 Mn 54,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 72.66 Mn
API Access

Clene Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CLNN&period=max&api_key=YOUR_API_KEY